These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Phenotype study of apolipoprotein E isoforms in hyperlipoproteinaemic patients. Ghiselli G; Gregg RE; Zech LA; Schaefer EJ; Brewer HB Lancet; 1982 Aug; 2(8295):405-7. PubMed ID: 6124804 [TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma. Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845 [TBL] [Abstract][Full Text] [Related]
26. Familial high-density lipoprotein deficiency (Tangier disease): the third Italian case. Bracco G; Dotti G; Levis F; David E; Saracco G; Rizzetto M; Verme G J Inherit Metab Dis; 1988; 11 Suppl 2():155-7. PubMed ID: 3141697 [No Abstract] [Full Text] [Related]
27. Clinical features of lipoprotein disorders. Lloyd JK Ric Clin Lab; 1982; 12(1):97-100. PubMed ID: 7089428 [No Abstract] [Full Text] [Related]
28. Classification of primary dyslipoproteinemias. Dargel R Exp Pathol; 1985; 27(2):67-78. PubMed ID: 3888651 [No Abstract] [Full Text] [Related]
29. [Phenotype change in hyperlipoproteinemias]. Meincke H Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):236-9. PubMed ID: 4085393 [TBL] [Abstract][Full Text] [Related]
30. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier). Schaefer EJ; Kay LL; Zech LA; Brewer HB J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397 [TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III). Utermann G Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616 [No Abstract] [Full Text] [Related]
32. Clinical syndrome and lipid metabolism in hereditary deficiency of apolipoproteins A-I and C-III, variant 1. Norum RA; Forte TM; Alaupovic P; Ginsberg HN Adv Exp Med Biol; 1986; 201():137-49. PubMed ID: 3099552 [No Abstract] [Full Text] [Related]
33. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins. Schmitz G; Assmann G; Rall SC; Mahley RW Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234 [TBL] [Abstract][Full Text] [Related]
34. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. Wang CS; Alaupovic P; Gregg RE; Brewer HB Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies to serum lipoproteins: their present and future use in biology and medicine. Watt RM; Carhart RL; Gentile TC; Watt TS Pharmacol Ther; 1985; 28(1):29-50. PubMed ID: 2414787 [No Abstract] [Full Text] [Related]
36. [Separation of lipoproteins as a function of their apolipoprotein composition. Clinical applications]. Fruchart JC Ann Biol Clin (Paris); 1986; 44(2):116-21. PubMed ID: 3092704 [No Abstract] [Full Text] [Related]